David E. Gilham
Impact in
- Oncology top 0.5%
- CAR-T cell therapy research
- Cancer Immunotherapy and Biomarkers
- Immunology top 1%
- Immune Cell Function and Interaction
- Immunotherapy and Immune Responses
- T-cell and B-cell Immunology
Papers in
- Oncology 76
- CAR-T cell therapy research 73
- Immunology 46
- Immune Cell Function and Interaction 29
- Immunotherapy and Immune Responses 22
- T-cell and B-cell Immunology 11
- Co-authors
- Robert E. Hawkins (45 shared papers)Eleanor J. Cheadle (14 shared papers)John S. Bridgeman (9 shared papers)Hinrich Abken (5 shared papers)Dominic G. Rothwell (12 shared papers)Peter L. Stern (7 shared papers)Н. А. Кириллова (9 shared papers)Gray Kueberuwa (5 shared papers)
- Journals
- Cancer Immunology Immunotherapy (8 papers)Blood (5 papers)The Journal of Immunology (5 papers)Journal of Clinical Oncology (5 papers)Journal of Immunotherapy (5 papers)
- Partner nations
- United KingdomUnited StatesBelgium
In The Last Decade
David E. Gilham
90 papers receiving 3.7k citations
Peers
Comparison fields: 5 of 99
- Oncology 2.9k
- Immunology 1.5k
- Genetics 738
- Biomedical Engineering 813
- Molecular Biology 996
Countries citing papers authored by David E. Gilham
This map shows the geographic impact of David E. Gilham's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by David E. Gilham with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites David E. Gilham more than expected).
Fields of papers citing papers by David E. Gilham
This network shows the impact of papers produced by David E. Gilham. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by David E. Gilham. The network helps show where David E. Gilham may publish in the future.
Co-authors
The 25 scholars most cited alongside David E. Gilham, linked wherever they have co-authored with each other. Click a name or a connecting line to browse the papers they share.
All Works
Showing the 20 most-cited of 90 papers — load more, or switch the sort, to bring in the rest.
| # | Work | ||
|---|---|---|---|
| 1 | 2017 | 309 | |
| 2 | 2005 | 255 | |
| 3 | 2010 | 204 | |
| 4 | 2007 | 166 | |
| 5 | 2012 | 146 | |
| 6 | 2017 | 138 | |
| 7 | 2008 | 101 | |
| 8 | 2013 | 91 | |
| 9 | 2010 | 90 | |
| 10 | 2010 | 85 | |
| 11 | 2007 | 81 | |
| 12 | 2012 | 80 | |
| 13 | 2015 | 78 | |
| 14 | 2023 | 74 | |
| 15 | 1998 | 73 | |
| 16 | 2004 | 64 | |
| 17 | 2015 | 63 | |
| 18 | 2018 | 63 | |
| 19 | 2010 | 61 | |
| 20 | 2020 | 60 |
About David E. Gilham
David E. Gilham is a scholar working on Oncology, Immunology, Molecular Biology, Genetics and Biomedical Engineering, having authored 90 papers that have together received 3.7k indexed citations. Recurring topics across this work include CAR-T cell therapy research (73 papers), Immune Cell Function and Interaction (29 papers), Immunotherapy and Immune Responses (22 papers), Virus-based gene therapy research (17 papers), Viral Infectious Diseases and Gene Expression in Insects (16 papers), T-cell and B-cell Immunology (11 papers), Nanowire Synthesis and Applications (8 papers) and Monoclonal and Polyclonal Antibodies Research (6 papers). The work is most often cited by research in Oncology (2.9k citations), Immunology (1.5k citations), Genetics (738 citations), Biomedical Engineering (813 citations) and Molecular Biology (996 citations). David E. Gilham has collaborated with scholars based in United Kingdom, United States and Belgium. Frequent co-authors include Robert E. Hawkins, Eleanor J. Cheadle, John S. Bridgeman, Hinrich Abken, Dominic G. Rothwell, Peter L. Stern, Н. А. Кириллова, Gray Kueberuwa, Ryan D. Guest and Richard W. Griffiths. Their work appears in journals such as Cancer Immunology Immunotherapy, Blood, The Journal of Immunology, Journal of Clinical Oncology and Journal of Immunotherapy.
Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.